What is the Future of Bispecific Antibodies in Cancer Therapy?
The future of BsAbs in cancer therapy looks promising. Ongoing research aims to improve their design, reduce toxicity, and expand their use across various cancer types. Combination therapies involving BsAbs and other modalities like checkpoint inhibitors or CAR-T cells are also being explored to enhance therapeutic efficacy.
